Pathophysiology and management of pulmonary infections in cystic fibrosis

RL Gibson, JL Burns, BW Ramsey - American journal of respiratory …, 2003 - atsjournals.org
This comprehensive State of the Art review summarizes the current published knowledge
base regarding the pathophysiology and microbiology of pulmonary disease in cystic …

Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening

JL Bobadilla, M Macek Jr, JP Fine… - Human mutation, 2002 - Wiley Online Library
Although there have been numerous reports from around the world of mutations in the gene
of chromosome 7 known as CFTR (cystic fibrosis transmembrane conductance regulator) …

A genetic profile of contemporary Jewish populations

H Ostrer - Nature Reviews Genetics, 2001 - nature.com
The Jews are an ancient people with a history spanning several millennia. Genetic studies
over the past 50 years have shed light on Jewish origins, the relatedness of Jewish …

The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

N Rave-Harel, E Kerem, M Nissim-Rafinia… - American journal of …, 1997 - ncbi.nlm.nih.gov
The splicing variant, 5T allele, in intron 8 of the cystic fibrosis transmembrane conductance
regulator (CFTR) gene was shown to be associated with partial penetrance of the clinical …

Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection

N Risch, H Tang, H Katzenstein, J Ekstein - The American Journal of …, 2003 - cell.com
The presence of four lysosomal storage diseases (LSDs) at increased frequency in the
Ashkenazi Jewish population has suggested to many the operation of natural selection …

Clinical and genetic risk factors for cystic fibrosis-related liver disease

M Wilschanski, J Rivlin, S Cohen, A Augarten… - …, 1999 - publications.aap.org
Objective. The aim of this study was to define the role of possible risk factors for the
development of cystic fibrosis (CF)-related liver disease and to analyze the association …

[HTML][HTML] Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population

GE Palomaki, SC Fitzsimmons, JE Haddow - Genetics in Medicine, 2004 - Elsevier
Purpose: To estimate CFTR mutation frequencies, clinical sensitivities (proportions of carrier
couples or affected fetuses detected), and birth prevalence estimates for broad racial/ethnic …

The molecular basis for disease variability in cystic fibrosis

B Kerem, E Kerem - European journal of human genetics, 1996 - nature.com
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene. The disease is characterized …

Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families

ND Kauff, P Perez-Segura, ME Robson… - Journal of Medical …, 2002 - jmg.bmj.com
METHODS Records of all patients seen by the Clinical Genetics Service at Memorial Sloan-
Kettering Cancer Center (MSKCC) from 1.6. 95 to 30.6. 01, who identified themselves as …

Genetic testing in Israel: an overview

G Rosner, S Rosner… - Annual review of genomics …, 2009 - annualreviews.org
In Israel, genetic screening and testing are widespread and are on the rise. The socialized
medical system, the governmental National Program for the Detection and Prevention of …